See more : Great China Holdings (Hong Kong) Limited (0021.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Ma Kuang Healthcare Holding Limited (4139.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ma Kuang Healthcare Holding Limited, a leading company in the Healthcare industry within the Healthcare sector.
- Danske Invest Mix (DKIMA.CO) Income Statement Analysis – Financial Results
- M Pictures Entertainment Public Company Limited (MPIC.BK) Income Statement Analysis – Financial Results
- National Retail Properties, Inc. (NNN) Income Statement Analysis – Financial Results
- APx Acquisition Corp. I (APXI) Income Statement Analysis – Financial Results
- Escrit Inc. (2196.T) Income Statement Analysis – Financial Results
Ma Kuang Healthcare Holding Limited (4139.TWO)
About Ma Kuang Healthcare Holding Limited
Ma Kuang Healthcare Holding Limited, an investment holding company, provides medical services in Taiwan and internationally. The company offers community medical services, Chinese medical services, Chinese medicines, medical management training courses, educational support services, etc. It also provides medical treatment, and overseas student homestay and guardianship services; management consultant services; Chinese medicine beauty services; consulting services, such as corporate management, computer technology, industry information, and marketing; and e-commerce sales services. In addition, the company operates clinics, educational institutions, community medicine clinics, and traditional Chinese medicine clinics. Further, it is involved in sale of dietary supplement, and pharmaceutical and medical goods in stores; restaurant business; and lease and other services. The company was incorporated in 2009 and is based in Kaohsiung, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.22B | 1.06B | 959.45M | 910.24M | 1.02B |
| Cost of Revenue | 1.05B | 898.05M | 786.29M | 734.83M | 843.13M |
| Gross Profit | 171.77M | 160.70M | 173.16M | 175.41M | 177.06M |
| Gross Profit Ratio | 14.10% | 15.18% | 18.05% | 19.27% | 17.36% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 146.11M | 126.68M | 127.85M | 115.24M | 0.00 |
| Selling & Marketing | -16.55M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 129.56M | 126.68M | 127.85M | 115.24M | 125.32M |
| Other Expenses | 17.42M | -16.88M | 33.27M | 67.67M | 37.61M |
| Operating Expenses | 146.98M | 126.68M | 127.85M | 115.24M | 162.93M |
| Cost & Expenses | 1.19B | 1.02B | 914.14M | 850.07M | 1.01B |
| Interest Income | 199.00K | 478.00K | 2.47M | 3.83M | 3.45M |
| Interest Expense | 43.33M | 26.72M | 22.47M | 21.06M | 21.09M |
| Depreciation & Amortization | 192.91M | 162.00M | 138.87M | 135.75M | 27.31M |
| EBITDA | 207.80M | 182.48M | 219.92M | 265.70M | 41.44M |
| EBITDA Ratio | 17.06% | 14.70% | 22.92% | 29.19% | 4.06% |
| Operating Income | 24.79M | -6.33M | 81.05M | 129.94M | 14.12M |
| Operating Income Ratio | 2.03% | -0.60% | 8.45% | 14.28% | 1.38% |
| Total Other Income/Expenses | -53.23M | -64.20M | -24.47M | -22.52M | 55.67M |
| Income Before Tax | -28.44M | -30.18M | 56.58M | 107.43M | 69.79M |
| Income Before Tax Ratio | -2.33% | -2.85% | 5.90% | 11.80% | 6.84% |
| Income Tax Expense | 11.18M | 5.34M | 14.62M | 7.95M | 5.44M |
| Net Income | -42.53M | -30.90M | 38.54M | 77.16M | 67.62M |
| Net Income Ratio | -3.49% | -2.92% | 4.02% | 8.48% | 6.63% |
| EPS | -1.00 | -0.73 | 0.91 | 1.81 | 1.59 |
| EPS Diluted | -1.00 | -0.73 | 0.90 | 1.81 | 1.59 |
| Weighted Avg Shares Out | 42.55M | 42.55M | 42.59M | 42.55M | 42.55M |
| Weighted Avg Shares Out (Dil) | 42.55M | 42.55M | 42.59M | 42.60M | 42.57M |
Source: https://incomestatements.info
Category: Stock Reports